Transmission of the Ebola virus remains widespread in West Africa, with infections among health care workers continuing to rise.
Although only 38% of respondents to a recent Pharmacy Times poll have ever reported an armed robbery at their pharmacies, the experience remains jarring for those who do report the crime.
The FDA’s Cardiovascular and Renal Drugs Advisory Committee has recommended the approval of edoxaban (Savaysa) for treating patients with nonvalvular atrial fibrillation, a type of arrhythmia that can potentially cause a stroke.
Three industry groups have collaborated to generate new approaches to care delivery through pharmacists that will lower medical costs and improve health outcomes.
Sometimes, the pharmacist just can’t leave the counter. At certain locations, that dedication persists even after death, leading to tales of spectral pharmacists causing mischief and strange events at their former pharmacies.
Police have taken suspects into custody in conjunction with recent armed robberies at Rite Aid and CVS pharmacies.
The World Health Organization convened a high-level emergency meeting with government leaders and pharmaceutical company representatives earlier this week to discuss issues surrounding access to experimental Ebola vaccines.